EXAGEN INC. — Director's Dealing 2025

Jun 12, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXAGEN INC. (XGN)
CIK: 0001274737
Period of Report: 2025-06-10

Reporting Person: Stokes Frank (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-06-10	Stock Option(right to buy)	$7.36	A	9000	Acquired	2035-06-09	Common Stock (9000)	Direct

Footnotes

F1: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.